These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2568571)

  • 1. Dynorphin A (1-13), microinjected into the preoptic area, stimulates water intake in rats.
    Shimizu H; Shimomura Y; Negishi M; Kobayashi I; Kobayashi S
    Life Sci; 1989; 45(1):25-30. PubMed ID: 2568571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine and dynorphin(1-13) microinjected into the medial preoptic area and nucleus accumbens: effects on sexual behavior in male rats.
    Band LC; Hull EM
    Brain Res; 1990 Jul; 524(1):77-84. PubMed ID: 1976031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of dynorphin A-(1-8), dynorphin A-(1-13) and dynorphin A-(1-17) microinjected into the preoptic medialis nucleus of the rat.
    Feuerstein G; Faden AI
    Neuropeptides; 1984 Dec; 5(1-3):295-8. PubMed ID: 6152328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastriatal injections of dynorphin A fragments potentiate the dorsal immobility response in rats.
    Meyer ME
    Pharmacol Biochem Behav; 1993 Feb; 44(2):329-32. PubMed ID: 8095341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate and alpha receptor antagonists block the pressor responses of conscious rats given intravenous dynorphin.
    Thornhill JA; Gregor L; Saunders WS
    Peptides; 1989; 10(1):171-7. PubMed ID: 2568623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranigral dynorphin-1-13 suppresses kindled seizures by a naloxone-insensitive mechanism.
    Bonhaus DW; Rigsbee LC; McNamara JO
    Brain Res; 1987 Mar; 405(2):358-63. PubMed ID: 2882815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay.
    Hooke LP; He L; Lee NM
    J Pharmacol Exp Ther; 1995 May; 273(2):802-7. PubMed ID: 7752083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin A modulates acute and chronic opioid effects.
    Hooke LP; He L; Lee NM
    J Pharmacol Exp Ther; 1995 Apr; 273(1):292-7. PubMed ID: 7714779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area in rats.
    Hamilton ME; Bozarth MA
    Life Sci; 1988; 43(11):941-6. PubMed ID: 2901022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin-(1-13) induces spontaneous feeding in rats.
    Morley JE; Levine AS
    Life Sci; 1981 Nov; 29(18):1901-3. PubMed ID: 7311723
    [No Abstract]   [Full Text] [Related]  

  • 14. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors.
    Gosnell BA; Levine AS; Morley JE
    Life Sci; 1986 Mar; 38(12):1081-8. PubMed ID: 2870405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of dynorphin-(1-13) on luteinizing hormone release in conscious castrated rats.
    Kinoshita F; Nakai Y; Katakami H; Imura H
    Life Sci; 1982 May; 30(22):1915-9. PubMed ID: 6287134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of rat globus pallidus neurons to microintophoretically applied mu and kappa opioid receptor agonists.
    Huffman RD; Frey JM
    Eur J Pharmacol; 1989 Nov; 170(3):179-91. PubMed ID: 2575994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat.
    Haaf JA; Maigret C; Andringa-Bakker EA; van Wimersma Greidanus TB
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):96-101. PubMed ID: 2880444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.